{"@context":{"@vocab":"https://schema.org/"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/sec/admin/check?name=J.%20Michael%20Pearson","name":"J. Michael Pearson","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://creativecommons.org/publicdomain/zero/1.0/","primary_source":"https://www.sec.gov/litigation/admin","generated_at":"2026-09-30T09:26:01.794Z"},"count":7,"matches":[{"release_number":"34-104991","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":"2026-03-13","respondents":"Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies Inc., J. Michael Pearson, Howard. B. Schiller, Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2026/34-104991.pdf","canonical_url":"https://api.morvs.ai/sec-admin/34-104991"},{"release_number":"34-100410","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":"2024-06-24","respondents":"Valeant Pharmaceuticals International, Inc., n/k/a Bausch Health Companies Inc., J. Michael Pearson, Howard B.Schiller, and Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-100410.pdf","canonical_url":"https://api.morvs.ai/sec-admin/34-100410"},{"release_number":"33-10810, 34-89443, AAER-4154","release_act":"33","file_number":"3-19900","publish_date":"2020-07-31","respondents":"J. Michael Pearson","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2020/33-10810.pdf","canonical_url":"https://api.morvs.ai/sec-admin/33-10810%2C%2034-89443%2C%20AAER-4154"},{"release_number":"34-99284","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":null,"respondents":"Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies Inc., J. Michael Pearson, Howard B. Schiller, Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-99284.pdf","canonical_url":"https://api.morvs.ai/sec-admin/34-99284"},{"release_number":"34-99468","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":null,"respondents":"Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies, Inc.; J. Michael Pearson; Howard B. Schiller; and Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-99468.pdf","canonical_url":"https://api.morvs.ai/sec-admin/34-99468"},{"release_number":"34-99516","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":null,"respondents":"Valeant Pharmaceuticals International, Inc., n/k/a Bausch Health Companies, Inc.,; J. Michael Pearson; Howard B. Schiller; and Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-99516.pdf","canonical_url":"https://api.morvs.ai/sec-admin/34-99516"},{"release_number":"34-100808","release_act":"34","file_number":"3-19899, 3-19900, 3-19901, 3-19902","publish_date":null,"respondents":"Valeant Pharmaceuticals International, Inc. n/k/a Bausch Health Companies Inc.; J. Michael Pearson; Howard B. Schiller; and Tanya R. Carro, CPA","primary_pdf_url":"https://www.sec.gov/files/litigation/admin/2024/34-100808.pdf","canonical_url":"https://api.morvs.ai/sec-admin/34-100808"}]}